Medicare Enrolled
Dr. Vivek Mangla, M.D.
Cardiovascular Disease · Lufkin, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mangla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mangla? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mangla
Dr. Vivek Mangla is a cardiovascular disease in Lufkin, TX, with 19 years in practice. Based on federal Medicare data, Dr. Mangla performed 14,193 Medicare services across 7,545 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mangla received a total of $60,575 from 30 pharmaceutical and/or device companies across 389 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mangla is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 2% volume in TX$ $60,575 industry payments
Medicare Practice Summary
Medicare Utilization ↗14,193
Medicare services
Top 2% in TX for cardiovascular disease
7,545
Unique beneficiaries
$113
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~747 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 4,090 | $86 | $350 |
| Electrocardiogram (EKG), 12-lead | 1,470 | $10 | $70 |
| Regadenoson injection (Lexiscan) for heart stress test | 1,461 | $42 | $200 |
| Echocardiogram, transthoracic | 933 | $129 | $975 |
| Heart muscle strain imaging | 655 | $26 | $88 |
| Ultrasound of both sides of head and neck blood flow | 376 | $116 | $650 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 370 | $309 | $2,175 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 369 | $84 | $396 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 366 | $45 | $525 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 366 | $26 | $250 |
| Hospital follow-up visit, moderate complexity | 341 | $57 | $125 |
| Ultrasound of leg arteries or artery grafts | 329 | $166 | $675 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 321 | $8 | $35 |
| Programming of dual lead pacemaker system | 242 | $54 | $250 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 213 | $19 | $250 |
| New patient office visit, complex (60-74 min) | 205 | $146 | $500 |
| Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | 192 | $124 | $750 |
| Programming of cardiac rhythm monitor system | 189 | $41 | $250 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 155 | $18 | $250 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 139 | $46 | $400 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 134 | $36 | $150 |
| Review by radiologist of additional artery image | 117 | $71 | $525 |
| Programming of multiple lead implantable defibrillator system | 114 | $69 | $250 |
| Initial hospital admission, high complexity | 110 | $122 | $375 |
| Ultrasonic guidance for blood vessel access | 98 | $28 | $75 |
| Remote pacemaker/defibrillator monitoring, 90 days | 88 | $15 | $250 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 80 | $16 | $55 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 74 | $692 | $3,750 |
| Review by radiologist of abdominal aorta and both leg arteries image | 60 | $114 | $712 |
| Remote pacemaker monitoring, 90 days | 58 | $20 | $250 |
| Programming of dual lead implantable defibrillator system | 54 | $72 | $250 |
| Review by radiologist of both arms or legs arteries image | 45 | $118 | $1,385 |
| Insertion of heart rhythm monitor under skin | 39 | $3,138 | $13,000 |
| Removal of plaque in artery of leg, initial vessel | 34 | $6,372 | $33,750 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 30 | $1,112 | $6,600 |
| Programming of single lead pacemaker system | 30 | $41 | $250 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 30 | $25 | $250 |
| Removal of plaque in arteries of leg | 28 | $4,545 | $33,000 |
| New patient office visit (45-59 min) | 26 | $107 | $450 |
| Ultrasound of heart with probe in esophagus, with report | 23 | $77 | $2,250 |
| Insertion of tube in right heart chambers for measurement | 21 | $626 | $2,700 |
| Coronary stent placement | 20 | $410 | $2,250 |
| External shock to heart to regulate heart beat | 18 | $75 | $550 |
| Ultrasound of heart blood flow, valves and chambers | 15 | $13 | $325 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 15 | $2 | $360 |
| Removal of heart rhythm monitor from under the skin | 14 | $48 | $1,200 |
| Balloon dilation of single coronary artery or branch | 14 | $293 | $1,800 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 11 | $814 | $3,800 |
| Cardiac catheterization | 11 | $344 | $4,200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.3% high complexity
27.1% medium
61.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$60,575
Total received (2018-2024)
Avg $8,654/year across 7 years
Top 10% in TX for cardiovascular disease
30
Companies
389
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$25,951 (42.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,831 (36.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$11,557 (19.1%)
Other
Charitable contributions, space rental, and other categories
$1,235 (2.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,135
2023$8,193
2022$26,588
2021$2,496
2020$329
2019$16,081
2018$3,753
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Shockwave Medical, Inc
$19,136
Abbott Laboratories
$18,655
ShockWave Medical, Inc
$6,600
Medtronic Vascular, Inc.
$3,563
Medtronic, Inc.
$3,500
BOSTON SCIENTIFIC CORPORATION
$1,630
ABIOMED
$1,396
AngioDynamics, Inc.
$1,235
Boston Scientific Corporation
$812
BIOTRONIK INC.
$716
Cardiovascular Systems Inc.
$681
Novartis Pharmaceuticals Corporation
$442
Janssen Pharmaceuticals, Inc
$368
E.R. Squibb & Sons, L.L.C.
$337
Amgen Inc.
$268
Merck Sharp & Dohme LLC
$264
Astellas Pharma US Inc
$215
PFIZER INC.
$163
Bard Peripheral Vascular, Inc.
$126
SANOFI-AVENTIS U.S. LLC
$80
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$78
Boehringer Ingelheim Pharmaceuticals, Inc.
$74
Biosense Webster, Inc.
$46
BARD PERIPHERAL VASCULAR, INC.
$45
Inari Medical, Inc.
$34
Allergan Inc.
$28
Philips Electronics North America Corporation
$28
Merck Sharp & Dohme Corporation
$26
Amarin Pharma Inc.
$15
EKOS Corporation
$11
Top 3 companies account for 73.3% of total payments
Associated products mentioned in payments ›
(9266) ELCA · ALLURE QUADRA · AMPLATZER · AMPLATZER AMULET · AMPLATZER Occluders · ARCTIC FRONT ADVANCE · AURYON LASER SYSTEM 100-120 VAC · AVEIR · Assurity Pacemaker · Auryon Laser System 100-120 Vac · BYSTOLIC · Baylis Medical Company Radiofrequency Puncture Generator · CAMZYOS · CARDIOMEMS · CARTO 3 · CHANTIX · CROSSER · CRT-Ds · CardioMEMS HF System · Carto 3 System · Confirm Rx · CoreValve Evolut · Corlanor · DYNAGEN · Diamondback Coronary · Diamondback Peripheral · EKOSONIC · ELIQUIS · ENSITE · ENSITE PRECISION · ENTRESTO · EP-WorkMate Claris System · EnSite Precision Cardiac Mapping System · EnSite Velocity System Expansion Modules · Ensite Cardiac Mapping System · FLOWTRIEVER CATHETER · GENERAL VASCULAR INTERVENTION · HAWKONE · HeartWare HVAD · Hi-Torque Whisper guide wire · Impella · JARDIANCE · LEQVIO · LEXISCAN · LINQ II · LUTONIX · LUX-Dx Insertable Cardiac Monitor · LifeVest · MERLIN@HOME · MICRA · MULTAQ · Merlin Connectivity and Remote · Micra · PRADAXA · PRALUENT · PULSESELECT · Peripheral Orbital Atherectomy System · QUADRA ASSURA · QUARTET · Quadra Assura CRT Defibrillator · Quartet CRT Lead · Ranger · Repatha · Reveal LINQ · Rhythmia Mapping System · S · SENSOR ENABLED · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SYNERGY · SensiTherm (ICE) · TACTICATH ABLATION CATHETER · TURBOHAWK · TactiCath Quartz CFA Catheter · VERQUVO · VIEWMATE · Vascepa · VersaCross Access Solution · WATCHMAN · WATCHMAN Access System · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (43%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 10% for cardiovascular disease in TX.
Equivalent to $427 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
11
Per 100K population
12.7
County median income
$58,847
Nearest hospital
WOODLAND HEIGHTS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Mangla is a clinical cardiology specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (speaking/promotional, top 10%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Mangla experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mangla performed 4,090 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mangla receive payments from pharmaceutical companies?
Yes. Dr. Mangla received a total of $60,575 from 30 companies across 389 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mangla's costs compare to other cardiovascular diseases in Lufkin?
Dr. Mangla's average Medicare payment per service is $113. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mangla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Lufkin
Browse cardiovascular diseases in Lufkin ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Shockwave Medical, Inc Payments to Doctors
See all physicians who received payments from Shockwave Medical, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
ShockWave Medical, Inc Payments to Doctors
See all physicians who received payments from ShockWave Medical, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology